Gus Bassani, PharmD
With the official go-live date of Nov. 1, 2023, imminent, many of those involved in pharmaceutical compounding at health systems still have questions about the fine points of the latest revisions to USP General Chapters <795> and <797> on nonsterile and sterile preparations, respectively.
On Sept. 15, the National Association of Boards of Pharmacy sponsored a webinar featuring representatives from the USP Compounding Expert Committee, which led the